LONG READControl of empty, full and partially filled capsids BioPhorum establishing an industry position on this critical quality attributePosition A consensus of BioPhorum member companies reject a proposed blanket minimum specification for percentage empty AAV capsids. Presently, it is premature and impractical to set a minimal specification of <30% empty capsids to apply to all AAV-based gene therapies in development.BioPhorum calls upon...
